Update shared on 06 Nov 2025
Fair value Decreased 21%Analysts have raised their price target for JELD-WEN Holding from $3.75 to $5.25, citing improved productivity and management actions addressing declining volumes. They also note ongoing challenges with leverage and negative price/cost trends.
Analyst Commentary
Recent analyst updates highlight a mix of optimism about recent operational improvements and caution about ongoing financial headwinds. Below is a summary of both the bullish and bearish points raised by industry watchers regarding JELD-WEN Holding's outlook.
Bullish Takeaways
- Bullish analysts are encouraged by clear productivity improvements observed during the second quarter, which signals better operational execution.
- Management's proactive steps to address declining volumes are seen as a positive indicator of responsive leadership and disciplined strategy.
- The upward revision in valuation reflects growing confidence that recent actions may lay the groundwork for more stable future growth.
- Moderation in the rate of price/cost decline later in the year could reduce pressure on margins and support a more favorable earnings trajectory.
Bearish Takeaways
- Analysts remain cautious about the company's elevated leverage, which may continue to constrain financial flexibility and limit near-term upside.
- The persistence of a negative price/cost spread is noted as a risk to ongoing margin improvement and profitability.
- Despite operational gains, volume declines remain a core challenge, raising concerns about the sustainability of recent progress.
- Some analysts maintain a wait-and-see approach as they look for evidence of further stabilization before turning more positive on the stock's growth prospects.
What's in the News
- Initiated a comprehensive strategic review of its Europe business, which accounted for approximately 28% of global revenue in 2024. The goal is to optimize its portfolio and drive long-term value (Key Developments).
- Announced plans to reduce its North America and Corporate workforce by about 850 positions, or roughly 11% of those teams, as part of ongoing efforts to improve operational efficiency by year end 2025 (Key Developments).
- Lowered revenue guidance for the full year 2025 to between $3.1 billion and $3.2 billion. This reflects a projected year-over-year core revenue decline of 10% to 13% (Key Developments).
- Disclosed a goodwill impairment charge of $196.9 million for the twelve months ended September 27, 2025, which is significantly higher than the previous year's $63.4 million (Key Developments).
Valuation Changes
- Fair Value has declined significantly from $4.55 to $3.59, indicating a less favorable near-term outlook.
- Discount Rate remains unchanged at 12.32%, reflecting a consistent view of risk in the valuation model.
- Revenue Growth projections have weakened, with the expected decline increasing from -0.57% to -0.74%.
- Net Profit Margin has fallen sharply from 2.72% to 0.55%, which points to tighter margins moving forward.
- Future P/E has risen substantially from 6.12x to 24.76x. This suggests a higher valuation relative to expected earnings.
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.
